Abstract
Summary
Patients with osteomalacia often visit the neurology department with conditions mimicking other myopathies. We analyzed clinical features of osteomalacia patients who visited the neurology department. These patients frequently presented with hypocalcemia, hypovitaminosis D, and pain with less severe weakness. Osteomalacia should be considered when patients present with pain and weakness.
Introduction
Osteomalacia is a disease of bone metabolism; however, some patients with osteomalacia initially visit the neurology department. As these patients often complain of weakness and gait disturbance, osteomalacia can be confused with other myopathies. We analyzed the clinical features of patients with osteomalacia who visited the neurology department.
Methods
We retrospectively reviewed the medical records. Osteomalacia was diagnosed based on symptoms, laboratory features, and imaging results. We compared the characteristics of patients with osteomalacia who visited the neurology department with (1) those who did not visit the neurology department and (2) patients with idiopathic inflammatory myopathy.
Results
Eighteen patients with osteomalacia visited the neurology department (NR group). The common etiologies in the NR group included tumors or antiepileptic medication, whereas antiviral medication was the most common in patients who did not visit the neurology department (non-NR group). The NR group showed lower serum calcium (p = 0.004) and 25-hydroxyvitamin D (p = 0.006) levels than the non-NR group. When compared with patients with inflammatory myopathy, both groups showed proximal dominant weakness. However, pain was more common in osteomalacia than in myopathy (p = 0.008), and patients with osteomalacia showed brisk deep tendon reflex more often (p = 0.017). Serum calcium (p = 0.003) and phosphate (p < 0.001) levels were lower in osteomalacia than in myopathy.
Conclusions
It was not uncommon for patients with osteomalacia to visit the neurology department. The clinical presentation of these patients can be more complex owing the superimposed neurological disease and accompanying hypocalcemia. Osteomalacia should be considered when patients present with pain and weakness.
Similar content being viewed by others
References
Bhan A, Rao AD, Rao DS (2010) Osteomalacia as a result of vitamin D deficiency. Endocrinol Metab Clin N Am 39:321–331
Girgis CM, Wong T, Ngu MC, Emmett L, Archer KA, Chen RC et al (2011) Hypophosphataemic osteomalacia in patients on adefovir dipivoxil. J Clin Gastroenterol 45:468–473
Minisola S, Peacock M, Fukumoto S, Cipriani C, Pepe J, Tella SH, Collins MT (2017) Tumour-induced osteomalacia. Nat Rev Dis Primers 3:17044
Pfeifer M, Begerow B, Minne HW (2002) Vitamin D and muscle function. Osteoporos Int 13:187–194
Irani PF (1976) Electromyography in nutritional osteomalacic myopathy. J Neurol Neurosurg Psychiatry 39:686–693
Smith R, Stern G (1969) Muscular weakness in osteomalacia and hyperparathyroidism. J Neurol Sci 8:511–520
Schott GD, Wills MR (1976) Muscle weakness in osteomalacia. Lancet 1:626–629
Benhamou J, Fontanges E, Streichenberger N, Petiot P (2015) Severe osteomalacia mimicking progressive myopathy. Int J Rheum Dis 20:1803–1804. https://doi.org/10.1111/1756-185x.12641
Fukumoto S, Ozono K, Michigami T, Minagawa M, Okazaki R, Sugimoto T, Takeuchi Y, Matsumoto T (2015) Pathogenesis and diagnostic criteria for rickets and osteomalacia—proposal by an expert panel supported by Ministry of Health, Labour and Welfare, Japan, the Japanese Society for Bone and Mineral Research and the Japan Endocrine Society. Endocr J 62:665–671
RMC Trial Group (2009) Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study. Lancet Neurol 8:158–164
Chong WH, Molinolo AA, Chen CC, Collins MT (2011) Tumor-induced osteomalacia. Endocr Relat Cancer 18:R53–R77
Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, Kurella Tamura M, Feldman HI (2014) KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis 63:713–735
Al-Said YA, Al-Rached HS, Al-Qahtani HA, Jan MM (2009) Severe proximal myopathy with remarkable recovery after vitamin D treatment. Can J Neurol Sci 36:336–339
Ripellino P, Terazzi E, Bersano E, Cantello R (2013) Adult osteomalacia: a treatable cause of “fear of falling” gait. Neurology 80:2079
Ladha SS, Whitaker MD, Bosch EP (2006) Oncogenic osteomalacia: muscular weakness and multiple fractures. Neurology 67:364–365
Panda S, Sharma K (2013) Osteomalacia induced peripheral neuropathy after obesity reduction surgery. Ann Indian Acad Neurol 16:690–692
Noh CK, Lee MJ, Kim BK, Chung YS (2013) A case of nutritional osteomalacia in young adult male. J Bone Metab 20:51–55
Assenza G, Campana C, Tombini M, Cosimo Quattrocchi C, Giambattistelli F, Benvenga A, Pellegrino G, Assenza F, Vernieri F, di Lazzaro V (2013) Osteomalacic myopathy: an uncommon side effect of antiepileptic drugs. Muscle Nerve 48:837–838
Valmadrid C, Voorhees C, Litt B, Schneyer CR (2001) Practice patterns of neurologists regarding bone and mineral effects of antiepileptic drug therapy. Arch Neurol 58:1369–1374
Pack AM (2003) The association between antiepileptic drugs and bone disease. Epilepsy Curr 3:91–95
Teagarden DL, Meador KJ, Loring DW (2014) Low vitamin D levels are common in patients with epilepsy. Epilepsy Res 108:1352–1356
Qari FA, Nasser TA (2013) Association between neurological and rheumatological manifestations in vitamin D deficiency and vitamin D levels. Pak J Med Sci 29:735–739
Ishikawa T, Saito M, Morishita H, Watanabe I (1995) Effect of hypocalcemia on muscle in disorders of calcium metabolism. Acta Paediatr Jpn 37:367–369
Hirata D, Nagashima T, Saito S, Okazaki H, Kano S, Minota S (2002) Elevated muscle enzymes in a patient with severe hypocalcemia mimicking polymyositis. Mod Rheumatol 12:186–189
Murphy E, Williams GR (2009) Hypocalcaemia. Medicine 37:465–468
Ali FE, Al-Bustan MA, Al-Busairi WA, Al-Mulla FA (2004) Loss of seizure control due to anticonvulsant-induced hypocalcemia. Ann Pharmacother 38:1002–1005
Gilchrist JM (1995) Osteomalacic myopathy. Muscle Nerve 18:360–361
Smith R, Stern G (1967) Myopathy, osteomalacia and hyperparathyroidism. Brain 90:593–602
Schubert L, DeLuca HF (2010) Hypophosphatemia is responsible for skeletal muscle weakness of vitamin D deficiency. Arch Biochem Biophys 500:157–161
Policepatil SM, Caplan RH, Dolan M (2012) Hypocalcemic myopathy secondary to hypoparathyroidism. WMJ 111:173–175
Glerup H, Mikkelsen K, Poulsen L, Hass E, Overbeck S, Andersen H, Charles P, Eriksen EF (2000) Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement. Calcif Tissue Int 66:419–424
Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, Staehelin HB, Bazemore MG, Zee RY, Wong JB (2004) Effect of vitamin D on falls: a meta-analysis. JAMA 291:1999–2006
Skaria J, Katiyar B, Srivastava T, Dube B (1975) Myopathy and neuropathy associated with osteomalacia. Acta Neurol Scand 51:37–58
Skaria J, Katiyar BC, Srivastava TP, Dube B (1975) Myopathy and neuropathy associated with osteomalacia. Acta Neurol Scand 51:37–58
Parsonage MJ, Wilkins EG, Snowden N, Issa BG, Savage MW (2005) The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy. HIV Med 6:341–346
Mateo L, Holgado S, Marinoso ML, Perez-Andres R, Bonjoch A, Romeu J et al (2016) Hypophosphatemic osteomalacia induced by tenofovir in HIV-infected patients. Clin Rheumatol 35:1271–1279
Jeong HJ, Lee JM, Lee TH, Lee JY, Kim HB, Heo MH, Choi G, Chae JN, Kim JM, Kim SH, Kwon KY (2014) Two cases of hypophosphatemic osteomalacia after long-term low dose adefovir therapy in chronic hepatitis B and literature review. J Bone Metab 21:76–83
Bingham CT, Fitzpatrick LA (1993) Noninvasive testing in the diagnosis of osteomalacia. Am J Med 95:519–523
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None.
Rights and permissions
About this article
Cite this article
Kim, S.W., Hong, N., Rhee, Y. et al. Clinical and laboratory features of patients with osteomalacia initially presenting with neurological manifestations. Osteoporos Int 29, 1617–1626 (2018). https://doi.org/10.1007/s00198-018-4501-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-018-4501-1

